SGLT2 Inhibitors Curb AF Post-Ablation Recurrences in T2D

Retrospective, observational data from more than 13,000 US patients with type 2 diabetes and atrial fibrillation suggest that SGLT2 inhibitor treatment may cut AF recurrences post-ablation.

Related Keywords

Massachusetts ,United States ,Burlington ,James Januzzi Jr ,Division Of Cardiovascular Medicine ,Trinetx Analytics Network ,Beth Israel Lahey Health ,Cardiovascular Medicine ,Lahey Hospital ,Medical Center ,Diabetes Mellitus Type 2 ,Iabetes Mellitus Type Ii ,Type 2 Diabetes ,Atrial Fibrillation ,F Atrial Fibrillation ,Sglt2 Inhibitors ,Odium Glucose Transporter 2 Inhibitors ,Odium Glucose Co Transporter 2 Inhibitors ,Sodium Glucose Cotransporter 2 Inhibitors ,Tablation ,Healthcare Technology ,Ealth Care Technology ,Electronic Medical Record Emr ,Electronic Medical Record ,Omputerized Medical Reco ,